Navigation Links
Chuback Medical Group Raises Awareness for the Serious Vein Condition Deep Vein Thrombosis
Date:3/19/2013

Paramus, NJ (PRWEB) March 19, 2013

Paramus, NJ. Chuback Medical Group, a leading vein treatment center in Bergen County, New Jersey, is doing its part to reach out to the public and raise awareness for a serious vein condition.

March is Deep Vein Thrombosis (DVT) month, and the Chuback Medical Group has joined in the effort to decrease the number of serious illnesses and deaths as a result of DVT. DVT is a condition in which blood clots form in the deep leg veins. Clots can break free and travel to the lungs, potentially causing pulmonary embolism. This can be fatal if not detected and treated early.

Under the direction of Dr. John Chuback, a top vein disease specialist in Bergen County, NJ, the vein clinic is using Facebook and Twitter to spread the word about this vein disorder. Chuback Medical Group has released an informative video about deep vein thrombosis to help empower the public to protect their health. Everyone should learn the symptoms and risk factors for this vein problem and seek venous disease treatment if needed.

For more information, go to:

Varicose Vein Treatment Options

Chuback Medical Group offers patients a variety of varicose vein and spider vein trea
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Presidents Bioethics Commission releases report on pediatric medical countermeasure research
2. Rejuv Medical Sponsoring Minnesota’s Annual iRock Run
3. M.D. International Studies Innovative Pre-Medical Courses Arrives in USA
4. Cloud Medical Doctor Software Corporation Finalizes Acquisition of Doctors Network of America and Expands its Medical Billing Services West
5. Innovative Medical Marijuana Growing Product added to PotLocator.com Lineup
6. Health2Go Announces Medical Research Showing DHEA Improves Health and Benefits Skin
7. Medical Marketing Firm MCPR Introduces Sports Medicine Expert for Media Interviews
8. UH Case Medical Center awarded highest certification as Comprehensive Stroke Center
9. Peter Piot awarded Hideyo Noguchi Africa Prize for Medical Research
10. Corporate Whistle Blower Center Urges Physicians To Call them--If They Have Proof A Medical Device Company Was Knowingly Selling Defective Products
11. Launch of Chinese-German Center for Bio-Inspired Materials at Mainz University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... The report, “Market Snapshot: Aesthetic Lasers ... Asia-Pacific” provides quantitative analysis of the three aesthetic ... body contouring devices, non-invasive body contouring devices and ... data by revenue and volume over the 2006 ... South Korea, Australia and India. It uses data ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water ... providing an 8 year warranty on its selected hot water ... up due to the impending winter season, it was important ... premium service that the company provides. As a result, Pro ... Wood and Bradford hot water tanks. , “Every installer ...
(Date:11/23/2014)... friends have more influence on teens, alcohol use than ... "We,ve known for a long time that ... use, but there are no common studies that distinguished ... influence on those decisions," Jonathon Beckmeyer, an assistant professor ... a university news release. Beckmeyer analyzed data gathered ...
(Date:11/23/2014)... a notable magnetic locks maker, has released a variety ... available at low rates up to 30% off. ... emergency doors. The emergency door adopts fireproof material and ... colors. All of the products are top-quality guaranteed. ... as easy as many people think. As a ...
(Date:11/23/2014)... November 23, 2014 To show thanks to ... new collection of white evening dresses for weddings. ... workers 24/7. , iFitDress.com is a distinguished dress manufacturer, and ... supported by worldwide customers for a very long time. The ... where a customer will be able to buy not only ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... Japan, May 30 Stronger health,systems, improved maternal and ... diseases are essential to African development,more than 40 heads ... highlighted in the action plan adopted at,the close of ... countries,were represented, along with many international organizations., Under ...
... sexual appetite. But stimulating new research in the Journal ... eye. A recent study shows that men who watched ... they were making decisions about money, soda, and candy. ... Luk Warlop (KULeuven, Belgium) found that the desire for ...
... study says , , FRIDAY, May 30 (HealthDay News) -- Repetitive ... the spine enough to result in a temporary loss of ... Previous research has suggested that gravity-related compression of the spine ... percent of their height in a normal day. Fortunately, this ...
... patients assume infertility is female issue, though almost half, infertility cases due ... ... factors, PURCHASE, N.Y., May 30 ... female condition, according,to an informal web survey conducted by IntegraMed, the leading ...
... 2008] Golf can be a good investment for the health, ... Karolinska Institutet. The death rate for golfers is 40 per ... age and socioeconomic status, which correspond to a 5 year ... the safest. , It is a well-known fact that ...
... 29, 2008) -- Physician-scientists from NewYork-Presbyterian Hospital/Columbia University ... at the American Society of Clinical Oncology Annual ... Among the most significant presentations are the following: ... Patients With Unresectable Metastatic Melanoma , Dr. Howard ...
Cached Medicine News:Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 2Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 3Health News:Football Can Shrink Players 2Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 2Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 3Health News:Golf prolongs life 2Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 2Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 3Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 4
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... James M. Gower is retiring from the board ... executive officer, and Raul Rodriguez , most recently serving ... the position of chief executive officer and join the board ... Board of Directors since 2005, will become chairman. Mr. Gower ...
(Date:11/24/2014)... , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... Joseph Kim , President and CEO of Inovio Pharmaceuticals, will ... team to ring the Nasdaq Opening Bell tomorrow, Tuesday November ... September 15 th listing on the Nasdaq Global Select ... Dr. Kim said, "We are honored to ring the Nasdaq ...
(Date:11/22/2014)...  Sprout Pharmaceuticals today announced positive preliminary results from a ... flibanserin up to 200 mg at bedtime had no next-day ... 20 th Annual Fall Scientific Meeting of the Sexual ... Miami . The Phase 1 ... Letter and the Formal Dispute Resolution that was filed in ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today ... 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) ... primary endpoint was the number of gout flares per ... ARCALYST at a weekly, self-administered, subcutaneous dose of either ...
... Feb. 28, 2011 Nile Therapeutics, Inc. (Nasdaq: ... development of novel therapeutics for cardiovascular disease, announced plans ... heart failure.  Nile plans to develop cenderitide (formerly CD-NP) ... decompensated heart failure (ADHF) patients continuously for up to ...
Cached Medicine Technology:ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 3ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 4ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 5ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 6ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 7ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 8ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 9ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 10Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 2Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 3Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 4
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... exclusively distributed by Medtronic, sets the ... intra-operative imaging with surgical navigation in ... is one of the most comprehensive ... Exceptional image quality from a low-field ...
Microwell EIA for detection of Calcitonin...
Mircrowell EIA for detection of Intact PTH...
Medicine Products: